Middle East and Africa Anticoagulant Reversal Drug Market Opportunities by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

Middle East and Africa Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, and AndeXXa); End User (Hospital Pharmacies, Retail Pharmacies, and Others)

Report Date : May 2021
Report Code : TIPRE00022196

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 129

Page Updated: May 2021

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The anticoagulant reversal drug market in Middle East and Africa is expected to grow from US$ 34.5 million in 2019 to US$ 75.4 million by 2027; it is estimated to grow at a CAGR of 10.9% from 2019 to 2027.

Rapidly progressing research activities in drug development of novel therapeutics across the world to counter the growing prevalence of cardiovascular diseases, such as atrial fibrillation is driving the growth of the anticoagulant reversal drugs market. There is always a need for innovative therapeutic approaches in the treatment of various cardiovascular indications. For instance, the study titled ‘Evaluation of andexanet alfa and four‐factor prothrombin complex concentrate (4F‐PCC) for reversal of rivaroxaban‐ and apixaban‐associated intracranial hemorrhages,’ published in February 2020, to investigate the efficacy of andexanet alfa in the treatment of intracranial hemorrhages (ICH).

Similarly, ‘Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC),’ published in March 2019, attempted to compare the activity of different novel reversal agents for direct-acting oral anticoagulants (DOAC). Thus, the increasing number of research activities is boosting the drug discovery activities and offering lucrative opportunities for the market growth across the industry.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the anticoagulant reversal drugs market. The Middle East and Africa anticoagulant reversal drugs market is expected to grow at a good CAGR during the forecast period.

21845-img1

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Middle East and Africa Anticoagulant Reversal Drug Market Segmentation

By Product

Prothrombin Complex Concentrates
Vitamin K
Protamine
Tranexamic Acid
Idarucizumab
AndeXXa

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Others

By Country

Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East and Africa

Companies Mentioned

Boehringer Ingelheim International GmbH
Pfizer Inc
Octapharma AG
Fresenius Kabi AG
Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
CSL Limited
Grifols, S.A.

Middle East and Africa Anticoagulant Reversal Drug Report Scope

Report Attribute	Details
Market size in 2019	US$ 34.5 Million
Market Size by 2027	US$ 75.4 Million
Global CAGR (2019 - 2027)	10.9%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Product Prothrombin Complex Concentrates Vitamin K Protamine Tranexamic Acid Idarucizumab AndeXXa By End User Hospital Pharmacies Retail Pharmacies
Regions and Countries Covered	Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Boehringer Ingelheim International GmbH Pfizer Inc Octapharma AG Fresenius Kabi AG Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals) CSL Limited Grifols, S.A.

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Middle East and Africa Anticoagulant Reversal Drug Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy